Evidence map›Paper›PMID 41350482›Full record

ArticleCurrent oncology reports2025

Non-pharmacological Supportive Care Interventions during Immunotherapy for People with Cancer: A Systematic Scoping Review and Future Directions.

Morgan J Farley, Brighid Scanlon, Megan Crichton, Ashley Bigaran, Amy Barnes, Nicolas H Hart, Patsy M Yates, Melissa Eastgate, Kim Alexander

Abstract readScoping Review
In one paragraph

Article in Current oncology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Morgan J FarleyCentre for Healthcare Transformation, School of Nursing, Queensland University of Technology, Brisbane, Australia. m.farley@qut.edu.au.ORCID 0000-0002-0434-720X
Brighid ScanlonCentre for Healthcare Transformation, School of Nursing, Queensland University of Technology, Brisbane, Australia.
Megan CrichtonCentre for Healthcare Transformation, School of Nursing, Queensland University of Technology, Brisbane, Australia.
Ashley BigaranWellness and Supportive Care, Olivia Newton-John Cancer & Wellness Centre, Heidelberg, VIC, Australia.
Amy BarnesCentre for Healthcare Transformation, School of Nursing, Queensland University of Technology, Brisbane, Australia.
Nicolas H HartCancer and Palliative Care Outcomes Centre, School of Nursing, Queensland University of Technology, Brisbane, Australia.
Patsy M YatesCentre for Healthcare Transformation, School of Nursing, Queensland University of Technology, Brisbane, Australia.
Melissa EastgateRoyal Brisbane and Women's Hospital, Cancer Care Services, Herston, Australia.
Kim AlexanderCentre for Healthcare Transformation, School of Nursing, Queensland University of Technology, Brisbane, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeImmunotherapy has transformed cancer treatment and outcomes. Patients receiving immunotherapy often encounter immune-related and treatment-related adverse events, leading to substantial supportive care needs. Currently, no recommendations exist to guide the use of non-pharmacological supportive care interventions for people with cancer undergoing immunotherapy treatments. This review aims to summarise the available evidence regarding non-pharmacological supportive care strategies to inform future clinical management and research directions.

methodsSix electronic databases (PubMed, CINAHL, EMBASE, PsycInfo, Web of Science and Scopus) were systematically searched for studies on non-pharmacological supportive care interventions for adults undergoing immunotherapy, published from October 2014 to October 2024.

resultsA total of 5383 studies were screened, with 14 meeting the inclusion criteria. Five were interventional studies and ten were observational. The interventional studies included three physical activity and exercise interventions, two dietary interventions, and one multimodal intervention. Most interventions were found to be feasible, acceptable, and demonstrate preliminary efficacy at improving quality of life, symptom burden, and clinical outcomes. Observational evidence demonstrated associations between physical activity and dietary factors and improved quality of life, reduced symptom burden, and improved clinical outcomes.

conclusionGrowing observational and preliminary interventional evidence suggests a multimodal supportive care intervention that includes regular symptom monitoring, dietary support and exercise to address the physical and psychosocial needs of cancer patients undergoing immunotherapy may be beneficial. However, further high-quality trials are needed to confirm their efficacy and inform clinical implementation.

Indexed as

ImmunotherapyNeoplasmsExerciseHumansQuality of LifeDietary interventionsExerciseGut microbiomeImmune checkpoint inhibitorImmune-related adverse eventsSupportive care

Identifiers

PMID41350482
PMCPMC12743693

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.